News

Tokyo CRO and Ecron Acunova have formed a strategic alliance strengthening their services in India, Europe and Japan providing sponsors with a global network. The alliance will provide

Shire has reported findings from a post hoc analysis examining emotional lability from Phase 3 study data with Vyvanse. In this study, Vyvanse demonstrated significant improvement in Attention-Deficit/Hyperactivity

Lexicon Pharmaceuticals has reported that the company’s investigational new drug, LX1031, a tryptophan hydroxylase (TPH) inhibitor, demonstrated positive results in clinically important parameters for the treatment of non-constipating

The researchers of Riken and Yokohama City University have reported that a key mechanism involved in immune surveillance in the intestinal system. Their research is expected to appear

The Medicines Company reported interim data from the evaluation of patients with acute hypertension and intracerebral hemorrhage with intravenous clevidipine treatment (ACCELERATE) trial. The study was presented at

BioAlliance has presented its results on a new oral chemotherapy nanoparticle formulation at the AAPS (American Association of Pharmaceutical Scientists) annual meeting in Los Angeles. The company claims,

Merck Eprova has signed an exclusive license agreement with Isofol Medical of Sweden to utilise Merck Eprova’s proprietary folate compound Modufolin in oncology. The use of Modufolin is

Abbott has entered into an agreement to acquire the global rights to PanGenetics’ PG110, a fully humanised antibody to Nerve Growth Factor (NGF). The move would expand the

Bioniche Pharma has reported the acquisition of Duraclon (clonidine hydrochloride injection) and Methadone Hydrochloride Injection USP from Xanodyne Pharmaceuticals. The company said that Duraclon (clonidine hydrochloride injection) has